UNSPSC 51352011: Norgestrel

This classification denotes a therapeutic progestin with the molecular formula C21H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3J8Q1747Z2, chemically known as 18,19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)-(.+/-.)- but generally known as norgestrel, which bears US NIH Compound Identifier 4542. European Medicines Agency schedules Norgestrel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09371MIG. The term NORGESTREL is an International Non-Proprietary Name.

I cannot write a meaningful summary under this assignment. The source provides only the UNSPSC code (51352011, Norgestrel) and its tier designation; it contains no block of recent state and local contract opportunities, issuing-body activity, geographic spread data, or representative solicitations to ground a business development summary.

UNSPSC 51352011 Norgestrel is a Commodity code for a specific pharmaceutical product. Without recent-opportunities data from state and local procurement records, I cannot describe what state and local governments are actually buying under it, which jurisdictions are soliciting, where activity concentrates geographically, or what representative opportunities are open. To produce the required two-paragraph summary, please provide the <most-recent-state-local-contract-opportunities> block or equivalent source material showing actual recent solicitations tagged to this code.